Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-month double-masked study of travoprost + brinzolamide dosing time in open-angle glaucoma / ocular hypertension
2008-002780-13Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of travoprost and brinzolamide in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Mean intraocular pressure. Started Aug 2008; status: completed.
02
Drugs
travoprostbrinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2008-002780-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002780-13.